Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Osada

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Annals of Hematology|February 19, 2018
Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphomaTomonori Nakazato, Satoshi Takanashi, Motoharu Hirano, et al.
Annals of Hematology|May 2, 2018
The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disordersSatoshi Takanashi, Tomonori Nakazato, Yoshinobu Aisa, et al.
Rheumatology International|July 6, 2017
Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regressionSatoshi Takanashi, Yoshinobu Aisa, Chisako Ito, et al.
Scientific Reports|February 8, 2023
Room-temperature spin injection from a ferromagnetic semiconductorShobhit Goel, Nguyen Huynh Duy Khang, Yuki Osada, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 10, 2020
Prognostic Impact of ABO Blood Group on Survival in Patients With Malignant LymphomaYuki Osada, Chisako Ito, Yuriko Nishiyama-Fujita, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 10, 2023
[Acute promyelocytic leukemia with asymptomatic cerebral hemorrhage]Satoshi Koi, Ayako Nogami, Hiroki Fujiwara, et al.
Cancer Medicine|March 8, 2026
Reduced-Dose Bendamustine as a First-Line Treatment of Follicular Lymphoma Is Associated With Poorer PrognosisKeisuke Tanaka, Atsushi Takahata, Yuma Noguchi, et al.
The Journal of Cell Biology|October 9, 2013
Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitinNaonobu Fujita, Eiji Morita, Takashi Itoh, et al.
International Journal of Hematology|November 9, 2025
Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study groupNoriyoshi Iriyama, Hitomi Nakayama, Masaru Nakagawa, et al.
International Journal of Hematology|October 2, 2025
Investigation of early mortality in the patients with newly diagnosed multiple myeloma: insights from a real-world cohort using J-CHAEGE-MM databaseMichihide Tokuhira, Hitomi Nakayama, Kohtaro Toyama, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Annals of Hematology|February 19, 2018
Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphomaTomonori Nakazato, Satoshi Takanashi, Motoharu Hirano, et al.
Annals of Hematology|May 2, 2018
The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disordersSatoshi Takanashi, Tomonori Nakazato, Yoshinobu Aisa, et al.
Rheumatology International|July 6, 2017
Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regressionSatoshi Takanashi, Yoshinobu Aisa, Chisako Ito, et al.
Scientific Reports|February 8, 2023
Room-temperature spin injection from a ferromagnetic semiconductorShobhit Goel, Nguyen Huynh Duy Khang, Yuki Osada, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 10, 2020
Prognostic Impact of ABO Blood Group on Survival in Patients With Malignant LymphomaYuki Osada, Chisako Ito, Yuriko Nishiyama-Fujita, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 10, 2023
[Acute promyelocytic leukemia with asymptomatic cerebral hemorrhage]Satoshi Koi, Ayako Nogami, Hiroki Fujiwara, et al.
Cancer Medicine|March 8, 2026
Reduced-Dose Bendamustine as a First-Line Treatment of Follicular Lymphoma Is Associated With Poorer PrognosisKeisuke Tanaka, Atsushi Takahata, Yuma Noguchi, et al.
The Journal of Cell Biology|October 9, 2013
Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitinNaonobu Fujita, Eiji Morita, Takashi Itoh, et al.
International Journal of Hematology|November 9, 2025
Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study groupNoriyoshi Iriyama, Hitomi Nakayama, Masaru Nakagawa, et al.
International Journal of Hematology|October 2, 2025
Investigation of early mortality in the patients with newly diagnosed multiple myeloma: insights from a real-world cohort using J-CHAEGE-MM databaseMichihide Tokuhira, Hitomi Nakayama, Kohtaro Toyama, et al.
Pageof 2